Inventor · disambiguated record
Jutta Deckert
Also filed as: DECKERT JUTTA
13 granted patents·12 pending applications·255 citations·filing 2007–2024
92Inventor score
Top patents by PatentIndex Score
25 records- 0195US8765917B2CD37-binding molecules and immunoconjugates thereofDECKERT JUTTA·Filed 2011·Granted Jul 1, 2014·31 cites·26 claims
- 0294US9346887B2CD37-binding molecules and immunoconjugates thereofIMMUNOGEN INC·Filed 2013·Granted May 24, 2016·12 cites·41 claims
- 0394US8153765B2Anti-CD38 antibodies for the treatment of cancerPARK PETER U·Filed 2007·Granted Apr 10, 2012·164 cites·30 claims
- 0490US11395796B2Anti-CD37 immunoconjugate and anti-CD20 antibody combinationsDEBIOPHARM INT SA·Filed 2018·Granted Jul 26, 2022·5 cites·10 claims
- 0590US10202460B2CD37-binding molecules and immunoconjugates thereofDEBIOPHARM INT SA·Filed 2016·Granted Feb 12, 2019·7 cites·22 claims
- 0689US11466095B2CD37-binding molecules and immunoconjugates thereofDEBIOPHARM INT SA·Filed 2018·Granted Oct 11, 2022·3 cites·21 claims
- 0789US10556958B2CD37-binding molecules and immunoconjugates thereofDEBIOPHARM INT SA·Filed 2016·Granted Feb 11, 2020·7 cites·20 claims
- 0889US9447189B2CD37-binding molecules and immunoconjugates thereofDECKERT JUTTA·Filed 2012·Granted Sep 20, 2016·13 cites·27 claims
- 0987US2025216392A1Novel anti-cd38 antibodies for the treatment of cancerSANOFI AVENTIS US LLC·Filed 2024·Application pending·0 cites
- 1085US9173961B2CD20 antibodies and uses thereofDECKERT JUTTA·Filed 2011·Granted Nov 3, 2015·8 cites·32 claims
- 1179US11104740B2Antibodies and assays for detection of CD37DEBIOPHARM INT SA·Filed 2016·Granted Aug 31, 2021·2 cites·19 claims
- 1275US12239732B2Anti-CD37 immunoconjugate and anti-CD20 antibody combinationsDEBIOPHARM INT SA·Filed 2022·Granted Mar 4, 2025·0 cites·12 claims
- 1372US2020408765A1Novel anti-cd38 antibodies for the treatment of cancerSANOFI SA·Filed 2020·Application pending·0 cites
- 1469US9314522B2Antitumors combinations containing antibodies recognizing specifically CD38 and bortezomibDECKERT JUTTA·Filed 2011·Granted Apr 19, 2016·3 cites·14 claims
- 1563US2020270361A1Cd37-binding molecules and immunoconjugates thereofDEBIOPHARM INT SA·Filed 2020·Application pending·0 cites
- 1660US2017343550A1Novel anti-cd38 antibodies for the treatment of cancerSANOFI SA·Filed 2017·Application pending·0 cites
- 1755US2012156218A1Novel anti-cd38 antibodies for the treatment of cancerPARK PETER U·Filed 2012·Application pending·0 cites
- 1855US2011262454A1Novel anti-cd38 antibodies for the treatment of cancerSANOFI AVENTIS·Filed 2011·Application pending·0 cites
- 1955US2017000900A1Anti-cd37 immunoconjugate and anti-cd20 antibody combinationsIMMUNOGEN INC·Filed 2016·Application pending·0 cites
- 2051US9175086B2CD20 antibodies and uses thereofDECKERT JUTTA·Filed 2011·Granted Nov 3, 2015·0 cites·37 claims
- 2147US2025213711A1Anti-canag antibody conjugateIKSUDA THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 2243US2016115238A1CD20 Antibodies and Uses ThereofIMMUNOGEN INC·Filed 2015·Application pending·0 cites
- 2343US2016108126A1CD20 Antibodies and Uses ThereofIMMUNOGEN INC·Filed 2015·Application pending·0 cites
- 2441US2018230218A1Met antibodies and immunoconjugates and uses thereofIMMUNOGEN INC·Filed 2018·Application pending·0 cites
- 2537US2015343077A1Anti-CD37 Immunoconjugate Dosing RegimensIMMUNOGEN INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jutta Deckert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →